Telerehabilitation-based Exercises vs Standard Home-based Exercise in Low Back Pain

April 28, 2026 updated by: Rodrigo Martín-San-Agustin, University of Valencia

Effect of the Implementation of Telerehabilitation-based Exercises Compared to the Standard Use of Exercise Dossier and Intervention Diary in a Home Therapeutic Exercise Intervention in Patients With Low Back Pain

The objective of the study is to compare the effect of a telerehabilitation-based exercise program, versus a home therapeutic exercise program scheduled through a dossier and an exercise diary, with respect to disability (measured using the OSWESTRY questionnaire) and other variables (range of motion, strength, fatigue, histological changes, pain, medication intake, psychosocial factors and adherence), in patients with low back pain.

Study Overview

Detailed Description

The objective of the study is to compare the effect of a telerehabilitation-based exercise program, versus a home therapeutic exercise program scheduled through a dossier and an exercise diary, with respect to disability (measured using the OSWESTRY questionnaire) and other variables (range of motion, strength, fatigue, histological changes, pain, medication intake, psychosocial factors and adherence), in patients with low back pain.

This randomized controlled trial has a parallel design, with two groups. Both groups will complete an 8-week home exercise program that includes flexibility and strength exercises. The program will be carried out with a frequency of 3 weekly sessions, preferably on alternate days. In the case of the experimental group, the program will be carried out with the support of the TRAK computer tool (https://www.trakphysio.com/es/), which allows the exercises to be carried out in front of a camera that, with the help of an artificial intelligence system, offers feedback to the participant and allows investigators/clinicians to keep a record of the sessions. In the case of the control group, the program will be carried out with the support of an information dossier of the exercises to be performed and a monitoring diary in which everything related to the sessions carried out will be noted. In both groups, as an addition to the home sessions, two face-to-face sessions will be held in the first and fifth weeks, respectively.

The exercise program includes flexibility and strength exercises, each made up of three levels of difficulty (easy, intermediate and difficult), with patients advancing to subsequent levels once each level is successfully overcome.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Select One
      • Valencia, Select One, Spain, 46010
        • Recruiting
        • University of Valencia
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Nonspecific subacute or chronic low back pain

Exclusion Criteria:

  • Neuropathic pain
  • Pain below the knees
  • Pain in legs with tingling, sensation of current or sensory alterations
  • Positive neurological tests. Lack of strength, sensitivity or altered reflexes
  • Canal stenosis
  • Nociplastic pain (fibromyalgia, generalized pain, emotional lability, affective and cognitive implications)
  • Previous lumbar surgery
  • Specific pathology (rheumatic, spondylolisthesis, oncological, fractures...)
  • Pregnancy
  • Performing medium-high intensity exercise of more than 100 minutes a week
  • Pathology that prevents exercise (decompensated cardiac pathology, decompensated respiratory pathology, significant mobility difficulties...)
  • Lack of digital skills
  • Visual problems that prevent exercise with the phone screen

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard home-based exercise
Home therapeutic exercise program scheduled through a dossier and an exercise diary
8 week home therapeutic exercise program that includes flexibility and strength exercises scheduled through a dossier and an exercise diary. The program will be carried out with a frequency of 3 weekly sessions, preferably on alternate days. The program will be carried out with the support of an information dossier of the exercises to be performed and a monitoring diary in which everything related to the sessions carried out will be noted.. As an addition to the home sessions, two face-to-face sessions will be held in the first and fifth weeks, respectively. The exercise program includes three levels of difficulty (easy, intermediate and difficult), with patients advancing to subsequent levels once each level is successfully overcome.
Experimental: Telerehabilitation-based exercises
Home therapeutic exercise intervention scheduled through a software of digital physiotherapy and telerehabilitation
8 week home therapeutic exercise program that includes flexibility and strength exercises scheduled through the software a digital physiotherapy and telerehabilitation. The program will be carried out with a frequency of 3 weekly sessions, preferably on alternate days. The program will be carried out with the support of the TRAK software (https://www.trakphysio.com/es/), which allows the exercises to be carried out in front of a camera that, with the help of an artificial intelligence system, offers feedback to the participant and allows you to keep a record of the sessions. As an addition to the home sessions, two face-to-face sessions will be held in the first and fifth weeks, respectively. The exercise program includes three levels of difficulty (easy, intermediate and difficult), with patients advancing to subsequent levels once each level is successfully overcome.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disability
Time Frame: 8 weeks measurement (post intervention)
Disability measured using the Oswestry Disability Index
8 weeks measurement (post intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle thickness (low back extensor muscles)
Time Frame: Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Muscle thickness (low back extensor muscles) measured using ultrasonography
Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Muscle thickness (transversus abdominis)
Time Frame: Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Muscle thickness (transversus abdominis) measured using ultrasonography
Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Medication intake
Time Frame: Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Medication intake registered using a diary
Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Disability
Time Frame: Baseline; 32 weeks measurement (24 weeks post intervention)
Disability measured using the Oswestry Disability Index (range score from 0 [less disability] to 100 [more disability])
Baseline; 32 weeks measurement (24 weeks post intervention)
Range of movement (Schober score)
Time Frame: Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Range of movement measured using the modified Schober score (a higher score is an indicator of better range of movement)
Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Range of movement (Finger floor distance test)
Time Frame: Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Range of movement measured using the Finger floor distance test (a lower distance is an indicator of better range of movement)
Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Extensor low back muscle strength
Time Frame: Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Extensor low back muscle strength measured using the Biering-Sorensen test (a higher score is an indicator of better strength)
Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Low Back Pain
Time Frame: Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Mean pain during last week measured with a numerical pain rating scale (range score from 0 [no pain] -10 [worst pain])
Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Kinesiphobia
Time Frame: Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Kinesiofobia measured using the Tampa Scale of Kinesiofobia (range score from 17 [lower levels of kinesiophobia]-68 [higher levels of kinesiophobia])
Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Depression
Time Frame: Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Depression measured using the Beck Depression Inventory (range score from 0 [better status] to 63 [severe depression])
Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Fear Avoidance Beliefs
Time Frame: Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Fear Avoidance Beliefs measured using the Fear Avoidance Belief Questionnaire (range score from 0 [Lower levels of fear-avoidance beliefs] to 96 [higher levels of fear-avoidace beliefs])
Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Fear Avoidance Components
Time Frame: Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Fear Avoidance Beliefs measured using the Fear Avoidance Components Scale (range score from 0 [Lower levels of fear-avoidance components] to 100 [higher levels of fear-avoidace components])
Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Adherence
Time Frame: Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Adherence measured using the TRAK application
Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Adherence
Time Frame: Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)
Adherence measured using an exercise diary
Baseline; 8 weeks measurement (post intervention); 32 weeks measurement (24 weeks post intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rodrigo Martín-San Agustín, PhD, University of Valencia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 4, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

May 31, 2024

First Submitted That Met QC Criteria

May 31, 2024

First Posted (Actual)

June 6, 2024

Study Record Updates

Last Update Posted (Actual)

April 29, 2026

Last Update Submitted That Met QC Criteria

April 28, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Standard home-based exercise

Subscribe